• Justin M. Hall
    1/30/12 5:40A ET: Rather than playing FAZ, investors ought to consider building positions in BIS - short biotech.
    1/30/12
    Reply (1)
    • Justin M. Hall: BIS represents a far better longer-term opportunity than say a FAZ - in my view.
      1/30/12
      From other sites